MaxCyte, Inc. (MXCT)
NASDAQ: MXCT · Real-Time Price · USD
1.580
+0.070 (4.64%)
At close: Nov 14, 2025, 4:00 PM EST
1.550
-0.030 (-1.90%)
After-hours: Nov 14, 2025, 7:34 PM EST
MaxCyte Market Cap
MaxCyte has a market cap or net worth of $168.54 million as of November 17, 2025. Its market cap has decreased by -54.80% in one year.
Market Cap
168.54M
Enterprise Value
80.98M
1-Year Change
-54.80%
Ranking
Category
Stock Price
$1.58
Market Cap Chart
Since the IPO on March 10, 2021, MaxCyte's market cap has decreased from $494.67M to $168.54M, a decrease of -65.93%. That is a compound annual growth rate of -20.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 14, 2025 | 168.54M | -61.67% |
| Dec 31, 2024 | 439.69M | -9.93% |
| Dec 29, 2023 | 488.14M | -12.55% |
| Dec 30, 2022 | 558.17M | -45.87% |
| Dec 31, 2021 | 1.03B | 108.47% |
| Mar 10, 2021 | 494.67M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 918.02B |
| Johnson & Johnson | 472.05B |
| AbbVie | 410.67B |
| UnitedHealth Group | 291.55B |
| AstraZeneca | 276.16B |
| Novartis AG | 252.58B |
| Merck & Co. | 230.63B |
| Abbott Laboratories | 227.08B |